Stock RPBC REDPOINT BIO CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Redpoint Bio Corporation

Equities

RPBC

US7577361030

Delayed OTC Markets
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Redpoint Bio Corporation -.--% -.--%
2013 Redpoint Bio Corporation cancelled the transaction announced on July 16, 2012. CI
2012 Redpoint Bio Corporation cancelled the acquisition of Celator Pharmaceuticals, Inc. from Domain Associates, L.L.C., BDC Diversified Venture Fund of BDC Venture Capital, GrowthWorks Access Fund Limited Partnership of Matrix Asset Management Inc., Quaker BioVentures, Thomas, McNerney & Partners, TL Ventures, Ventures West Management Inc. and others. CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RPBC Stock
  4. News Redpoint Bio Corporation
  5. MarketScreener Editorial Features